Key result
The ACE I/I genotype was significantly more frequent in type 2 diabetes mellitus cases compared to controls (28.73% vs 13.63%; p=0.003).
Why the study?
Are ACE and FABP2 gene polymorphisms associated with susceptibility to type 2 diabetes mellitus in the North Indian population?
Case-Control (n=300)
Are ACE and FABP2 gene polymorphisms associated with susceptibility to type 2 diabetes mellitus in the North Indian population?
The ACE I/I genotype is associated with an increased susceptibility to type 2 diabetes mellitus in the North Indian population.
BACKGROUND: Type 2 diabetes mellitus (T2DM) is growing in an epidemic manner across the world with an expected doubling of the incidence to millions of affected individuals in the last decades. At present, adequate data are not available regarding the ACE and FABP2 polymorphisms and their susceptibility with T2DM cases in the North Indian population. Thus we conceived the need for further study of ACE (I/D) and FABP2 (Ala54Thr) genes polymorphism and its susceptibility to T2DM in the North Indian population. MATERIALS AND METHODS: In this study, a total of 300 subjects (including 190 T2DM cases and 110 controls) participated. ACE and FABP2 gene polymorphisms in the cases and controls were evaluated by polymerase chain reaction and restriction fragment length polymorphism. RESULTS: The frequencies of ACE I/I, I/D and D/D genotypes in T2DM cases and controls were 28.73%, 55.17%, 16.09% and 13.63%, 57.95%, 28.40%, respectively. The frequencies of FABP2 Ala54Ala, Ala54Thr and Thr54Thr in T2DM cases were 18.39%, 66.66%, 14.94% and 22.72%, 61.36%, 15.90% in controls, respectively. ACE I/I genotype was significantly more frequent in cases as compared to controls (p = 0.003, χ(2) = 9.13). CONCLUSION: It appears that the ACE I/I genotype frequency was significantly higher in the T2DM cases as compared to the controls.
No takes yet. Share an insight, caveat, or question.
Raza et al. (2013) conducted a case-control in Type 2 diabetes mellitus (n=300). ACE and FABP2 gene polymorphisms vs. Controls (without T2DM) was evaluated on Frequency of ACE I/I genotype (p=0.003). The ACE I/I genotype was significantly more frequent in type 2 diabetes mellitus cases compared to controls (28.73% vs 13.63%; p=0.003).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: